Message Font: Serif | Sans-Serif
No. of Recommendations: 0
I certainly agree that a biotech partnership/purchase would be cool.

I wonder how much of the softness in KG price is a result of the general malaise being experienced by big pharma.

It is interesting to note that MRK is in the tank mostly because its pipeline has been decimated by cancer showing up in mice and it is hanging out to dry. It will come back some time, but it demonstrates the hazard of relying on in-house pipeline to cover expiring patents.

That is why my only portfolio pharmas are heavy KG and light ISIS. ISIS, of course, is a pure speculation, however they are having spectacular results in demonstrating the efficacy of their anti-sense theories in human subjects.

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.